<

 
Data updated 2025-05-02 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date17844404.8 (espacenet)  (Federated)  (European Patent Register), 20170824
Patent/reg. no. and dateDK/EP 3504229, 20211013
Publication date20190703
Priority no. and dateUS 201662378978 P, 20160824, US 201762443981 P, 20170109, US 201762545778 P, 20170815
EP pub. no. and date EP 3504229 20190703
Effective date
Applicant/ownerSangamo Therapeutics, Inc., 7000 Marina Blvd
Brisbane, CA 94005, US
Applicant ref. no.1615804
InventorMILLER, Jeffrey C., c/o Sangamo Therapeutics Inc.
7000 Marina Blvd
Brisbane
California 94005, US,
REBAR, Edward J., c/o Sangamo Therapeutics Inc.
7000 Marina Blvd
Brisbane
California 94005, US
RepresentativeRWS Group, RWS Compass House Vanwall Business Park, Vanwall Road Maidenhead, Berkshire SL6 4UB, GB
Opponent
IPC ClassA61K 35/28 (2015.01) , A61K 38/00 (2006.01) , A61P 7/00 (2006.01) , A61P 7/06 (2006.01) , C12N 15/90 (2006.01) , C12N 9/22 (2006.01) 
TitleREGULERING AF GENEKSPRESSION VED ANVENDELSE AF MANIPULEREDE NUKLEASER
Int. application no.US2017048397
Int. publication no.WO2018039440
Related patent (certificate)
StatusBortfaldet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact